- Home
- CRGX vs MHD Comparison
CRGX vs MHD Comparison
Compare CRGX & MHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- MHD
- Stock Information
- Founded
- CRGX 2021
- MHD N/A
- Country
- CRGX United States
- MHD United States
- Employees
- CRGX N/A
- MHD N/A
- Industry
- CRGX
- MHD Investment Bankers/Brokers/Service
- Sector
- CRGX
- MHD Finance
- Exchange
- CRGX Nasdaq
- MHD Nasdaq
- Market Cap
- CRGX 621.4M
- MHD 620.5M
- IPO Year
- CRGX 2023
- MHD N/A
- Fundamental
- Price
- CRGX $12.39
- MHD $11.96
- Analyst Decision
- CRGX Strong Buy
- MHD
- Analyst Count
- CRGX 6
- MHD 0
- Target Price
- CRGX $31.80
- MHD N/A
- AVG Volume (30 Days)
- CRGX 280.8K
- MHD 124.9K
- Earning Date
- CRGX 11-12-2024
- MHD 01-01-0001
- Dividend Yield
- CRGX N/A
- MHD 4.16%
- EPS Growth
- CRGX N/A
- MHD N/A
- EPS
- CRGX N/A
- MHD N/A
- Revenue
- CRGX N/A
- MHD N/A
- Revenue This Year
- CRGX N/A
- MHD N/A
- Revenue Next Year
- CRGX N/A
- MHD N/A
- P/E Ratio
- CRGX N/A
- MHD N/A
- Revenue Growth
- CRGX N/A
- MHD N/A
- 52 Week Low
- CRGX $10.91
- MHD $9.92
- 52 Week High
- CRGX $33.92
- MHD $12.18
- Technical
- Relative Strength Index (RSI)
- CRGX 39.66
- MHD 50.46
- Support Level
- CRGX $10.91
- MHD $11.66
- Resistance Level
- CRGX $15.75
- MHD $12.05
- Average True Range (ATR)
- CRGX 1.20
- MHD 0.14
- MACD
- CRGX -0.11
- MHD 0.04
- Stochastic Oscillator
- CRGX 30.08
- MHD 76.36
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About MHD Blackrock MuniHoldings Fund Inc.
Blackrock Muniholdings Fund Inc is a closed-end management investment company. The fund's objective is to provide shareholders with current income exempt from U.S. federal income taxes. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.